Navigation Links
Pharmasset to Present at Lazard Capital Markets Healthcare Conference
Date:11/9/2009

e analogs, a class of compounds which act as alternative substrates for the viral polymerase thus inhibiting viral replication. We currently have three clinical-stage product candidates. RG7128, a nucleoside analog for chronic HCV infections, is in a Phase 2b clinical trial in combination with Pegasys® plus Copegus® and is also in INFORM studies, the first series of studies designed to assess the potential of combinations of small molecules without Pegasys® and Copegus® to treat chronic HCV. These clinical studies are being conducted through a strategic collaboration with Roche. Our other clinical stage candidates include PSI-7851, an unpartnered, next generation HCV nucleotide analog, has completed initial Phase 1 clinical studies which provided supportive safety and efficacy data to initiate a Phase 2a trial in 1Q 2010 and Racivir, for the treatment of HIV, which has completed a Phase 2 clinical trial. We have also recently announced the nomination of two purine nucleotide analogs, PSI-938 and PSI-879, for preclinical development.

Pegasys(®) and Copegus(® )are registered trademarks of Roche.

    Contact
    Richard E. T. Smith, Ph.D.
    VP, Investor Relations and Corporate Communications
    richard.smith@pharmasset.com
    Office: +1 (609) 613-4181

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including, without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involv
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
2. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
3. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
4. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
5. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
6. Pharmasset Reports Fiscal Year End 2008 Financial Results
7. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
8. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
9. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
10. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. Browse the full ...
(Date:7/10/2014)... 11, 2014  Major advances in radiation therapy ... being highlighted in a three-day Oncology Summit taking ... July, 2014.  Renowned national and international cancer experts from ... and exchange knowledge on modern technologies making treatment ... The Summit will address a ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... /PRNewswire-iReach/ -- Machine Solutions Inc. (MSI) ... Capital Investors, LLC, an investment firm targeting long-term ... manufacturing sector.  Forsyth Capital has established a majority ... senior management team (Daniel Kasprzyk and Thomas Motsenbocker) ...
... Calif., Nov. 22, 2011 Avanir Pharmaceuticals, Inc. (NASDAQ: ... in the Piper Jaffray 23rd Annual Health Care Conference. ... NY Wednesday November 30, 2011 2:00 p.m. ET ... of this presentation will be available at http://www.avanir.com . ...
Cached Medicine Technology:Machine Solutions Inc. Partners With Forsyth Capital Investors, LLC 2
(Date:7/13/2014)... North American water storage systems market is estimated to grow ... at a CAGR of 21.0%, from 2013 to 2018. The ... in North America. The U.S. is experiencing high growth on ... and collection, and the increased spending on modernization and upgradation ... rate in Canada, and is rising at a rapid pace ...
(Date:7/13/2014)... 2014 Advanced boilers are preferred ... amount of fossil fuels, produce high-capacity power, emit ... increased global warming and climate change concerns, many ... harmful gas emissions and pollutants coming from fossilfuel-based ... the global advance boilers market., The global power ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study on ... 3D rendering; Layout and Animation; Image Reconstruction]: Global ... which analyzes and studies the major market drivers, ... Eastern Europe, Middle East and Africa, Asia-Pacific and ... landscape of the 3D imaging market, providing an ...
(Date:7/13/2014)... The Pearland, Texas location of The Little Gym, ... months to 12 years of age that offers everything from ... and Summer Camps, is now under new ownership. , Kevin ... after spending over six years at The Little Gym of ... , Berry has over ten years of experience working with ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special occasion dress ... of gorgeous Quinceanera dresses . , ... Quinceanera outfits is huge. Therefore, 2014QuinceaneraDresses.com is striving ... newly released dresses are made according to the ... vivid. , It is worthy of mention ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2
... believed to be the first U.S. study designed to prevent ... the Johns Hopkins Children,s Center have found that a family-based ... disorder among these children. , Despite its small size, ... sessions of cognitive behavioral therapy go a long way to ...
... and Services (CBay), the leading provider of transcription ... Transcription Company Partnership Program. The program is ... by providing a "wholesale" product and service offering ... as part of its initiative to expand the ...
... May 31 Today, the Center for Reproductive Rights ... provider Dr. George Tiller. Dr. Tiller was murdered entering ... few physicians in the country who provides abortions later ... anti-choice movement for over two decades. Recently, the Center ...
... CHICAGO, IL (May 31, 2009) - New research quantifies ... on gastrointestinal (GI) health. Both studies being presented this ... ) offer concrete evidence that the environment and ... insights into new directions for future research. DDW is ...
... The American Society for Gastrointestinal Endoscopy (ASGE) will honor important ... ASGE Crystal Awards on Sunday, May 31. Hosted by ASGE ... 6:30 p.m. at Navy Pier in Chicago. , Held ... Awards symbolize the finest in leadership, research and scientific pursuit. ...
... 31 Impac Software, part of the Elekta Group, ... of the Year award to Deanna Derdelinghen, ... Center in Stamford, Connecticut.Impac Software,s Registrar of the Year ... make valuable contributions to the success of their registry ...
Cached Medicine News:Health News:Hopkins study: When adult patients have anxiety disorder, their children need help too 2Health News:CBay Announces the MTSO Partnership Program to Drive Digital Health Record Adoption 2Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 2Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 3Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 4Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 5Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 6Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 7Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 8Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 9Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 10Health News:Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 11Health News:To what extent can environmental pollutants and alcohol affect GI health? 2Health News:To what extent can environmental pollutants and alcohol affect GI health? 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 2Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 4Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 5Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 6Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 7Health News:Impac Software Selects 2009 Cancer Registrar of the Year 2Health News:Impac Software Selects 2009 Cancer Registrar of the Year 3
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Inquire...
... Filters are ideal for PCR ... for any work where aerosol ... designed for pipetting DNA/RNA solutions, ... other. For applications requiring absolute ...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
Medicine Products: